Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death

Patients presenting with syncope for which VA is documented, or thought to be a likely cause, should be hospitalized for evaluation, monitoring, and management. (I, B-NR)

In patients with heart failure with reduced ejection fraction (HFrEF) (LVEF ≤40%), treatment with a beta blocker, a mineralocorticoid receptor antagonist and either an angiotensin-converting enzyme inhibitor, an angiotensin-receptor blocker, or an angiotensin receptor-neprilysin inhibitor is recommended to reduce SCD and all-cause mortality. (I, A)